摘要
目的:探讨伊曲康唑治疗重症血液病患者深部真菌感染的疗效。方法:回顾性分析我院在2010年2月到2012年2月收治的40例重症血液病患者的临床资料。结果:本组40例患者的治疗的总有效率为87.5%(35/40),不良反应发生率为10.0%(4/40),其表现为消化系统反应、肝功能损害以及水肿。结论:临床对重症血液病患者深部真菌感染实施伊曲康唑安全有效,值得临床推广应用。
Objective：invTo estigate the treatment of severe hematological diseases of itraconazole in the treatment of deep fungal infection in patients with curative effect.Methods：Retrospective analysis of our hospital in 2010 February to 2012 February treated 40 cases of severe hematological disorders in patients with clinical data.Results：In this group of 40 patients treated with total effective rate was 87.5%（35／/40 ）, the rate of adverse reactions was 10%（4／/40）,its performance for digestive system reaction, liver function damage and edema.Conclusion：Clinical on severe blood disease patients with deep fungal infection is safe and effective implementation of itraconazole, worth;clinical application.
出处
《中国医药导刊》
2013年第9期1480-1480,1482,共2页
Chinese Journal of Medicinal Guide
关键词
伊曲康唑
重症血液病
真菌感染
效果
Itraconazole Severe hematologic disease Fungal infection Effect
